UNDERSTANDING THE MECHANISM OF SGLT2 INHIBITOR IN YOUNG PERSONS WITH TYPE 2 DIABETES USING SINGLE-CELL RNA-SEQ DATA
Back
Abstract Number
WCN23-0472
Categories
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Diabetic Kidney Disease, Drugs and Treatments
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
UNDERSTANDING THE MECHANISM OF SGLT2 INHIBITOR IN YOUNG PERSONS WITH TYPE 2 DIABETES USING SINGLE-CELL RNA-SEQ DATA
Co-authors
Alakwaa, F.(1)*;Schaub , J.(1);Mccown , P.(1);Naik , A.(1);Eddy , S.(1);Nair , V.(1);Pyle, L.(2);Hodgin, J.(1);Brosius , F.(3);Nelson, R.(4); Kretzler, M.(1);Bjornstad, P.(5);
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)University Of Michigan, Internal Medicine, Ann Arbor, United States;(2)University Of Colorado School Of Medicine, Department Of Pediatrics, Aurora, United States;(3)The University Of Arizona College Of Medicine Tucson, Division Of Nephrology, Tucson, United States;(4)National Institute Of Diabetes And Digestive And Kidney Diseases, Chronic Kidney Disease Section, Phoenix, United States;(5)University Of Colorado School Of Medicine, Department Of Medicine, Aurora, United States;
E-Poster
https://storage.unitedwebnetwork.com/files/1041/a0bf082f82b073d071ab01f8e523e7af.pptx
Audio File
https://storage.unitedwebnetwork.com/files/1041/4f52c97cb155f8c5a0666ffa04b3ab19.mp4
if any